Serum amyloid A is a marker for pulmonary involvement in systemic sclerosis.
Inflammation in systemic sclerosis (SSc) is a prominent, but incompletely characterized feature in early stages of the disease. The goal of these studies was to determine the circulating levels, clinical correlates and biological effects of the acute phase protein serum amyloid A (SAA), a marker of...
Main Authors: | Katja Lakota, Mary Carns, Sofia Podlusky, Katjusa Mrak-Poljsak, Monique Hinchcliff, Jungwha Lee, Matija Tomsic, Snezna Sodin-Semrl, John Varga |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0110820&type=printable |
Similar Items
-
Increased Responsiveness of Human Coronary Artery Endothelial Cells in Inflammation and Coagulation
by: Katja Lakota, et al.
Published: (2009-01-01) -
Serum Amyloid A Activation of Inflammatory and Adhesion Molecules in Human Coronary Artery and Umbilical Vein Endothelial Cells
by: K. Lakota, et al.
Published: (2007-05-01) -
Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells.
by: Tadeja Kuret, et al.
Published: (2018-01-01) -
Titanium Dioxide Nanotube Arrays for Cardiovascular Stent Applications
by: Ita Junkar, et al.
Published: (2020-03-01) -
Analysis of Drug Effects on Primary Human Coronary Artery Endothelial Cells Activated by Serum Amyloid A
by: K. Lakota, et al.
Published: (2018-01-01)